Page last updated: 2024-11-05

trimethoprim and Ophthalmia Neonatorum

trimethoprim has been researched along with Ophthalmia Neonatorum in 1 studies

Trimethoprim: A pyrimidine inhibitor of dihydrofolate reductase, it is an antibacterial related to PYRIMETHAMINE. It is potentiated by SULFONAMIDES and the TRIMETHOPRIM, SULFAMETHOXAZOLE DRUG COMBINATION is the form most often used. It is sometimes used alone as an antimalarial. TRIMETHOPRIM RESISTANCE has been reported.
trimethoprim : An aminopyrimidine antibiotic whose structure consists of pyrimidine 2,4-diamine and 1,2,3-trimethoxybenzene moieties linked by a methylene bridge.

Ophthalmia Neonatorum: Acute conjunctival inflammation in the newborn, usually caused by maternal gonococcal infection. The causative agent is NEISSERIA GONORRHOEAE. The baby's eyes are contaminated during passage through the birth canal.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Laudat, P1
Lorette, G1
Quentin, R1
Subes, C1
Audurier, A1

Reviews

1 review available for trimethoprim and Ophthalmia Neonatorum

ArticleYear
[Treatment of gonococcal infections: current information].
    Annales de medecine interne, 1982, Volume: 133, Issue:7

    Topics: Anti-Infective Agents; Arthritis, Infectious; Cephalosporins; Child; Doxycycline; Erythromycin; Fema

1982